Foreground Capital

AOA Dx was just featured on CBS News Health Watch for their work in early ovarian cancer detection! The segment highlights the collaboration with Dr. Kian Behbahani, Dr. Benjamin Bitler, and the Ovarian Cancer Innovations Group at the University of Colorado Anschutz Medical Campus a partnership that has been instrumental in advancing AOA’s test! Learn more about AOA's pioneering work in early detection for ovarian cancer here: CC: Anna Milik Jeter Oriana Papin-Zoghbi Alexander Fisher

"Investment in women’s health reached an all-time high in 2024, driven by growing recognition of the ways various health conditions affect women differently and disproportionately, and the causes and biological drivers behind this imbalance. While women’s health startups will face headwinds in 2025 such as investor reluctance and scarce exits, the long-term potential of the sector remains undeniable." SVB's latest report examines the factors driving the record-breaking investment in venture-backed women’s health startups. Increased awareness of the ailments that women uniquely face is leading to increased growth and a very promising future for improvements in diagnosing and treating the care needs for women and individuals with female biologies" Congrats to the authors Jackie Spencer, Julie Betts Ebert, Nina Kandilian Nuzi Barkatally, Alexander Lennox-Miller, Timot Lamarre, and Raysa Bousleiman! Thank you for featuring us as a leading women's health fund and for all the work that was put into this report to showcase the traction in women's health. #womenshealth #healthcare #health

Join our webinar on April 8th, co-organized by Artemis and Locust Walk: “Pitch Perfect: How to Win Investors for Women’s Health”   🔎 Discover how to 𝗰𝗿𝗮𝗳𝘁 a compelling pitch that attracts investors 👩🎓 Learn key elements that 𝗵𝗲𝗹𝗽 your startup stand out among the competition 💡 Understand the strategies that 𝗲𝗻𝗰𝗼𝘂𝗿𝗮𝗴𝗲 successful funding outcomes ► 𝗥𝗲𝗴𝗶𝘀𝘁𝗲𝗿 𝗵𝗲𝗿𝗲: https://lnkd.in/eFyg7iyk Join us as CEO Patric Stenberg from Gesynta Pharma, who just raised a successful Series B round, shares his insights alongside Stasia Obremskey, a leading Women's Health investor from Foreground Capital. The conversation will also feature industry insights by Kaitlin DeMarco from Locust Walk, who will cover current market trends, valuation insights, financing strategies, and how to navigate a due diligence process. Don't miss this opportunity and learn how to understand and meet investor expectations in today’s challenging investment climate.   This event is brought to you by: - Artemis Women's Health Foundation, a non-profit organization fostering healthcare innovation for women worldwide, and - Locust Walk, a global investment bank supporting innovative life science companies in corporate development and capital raising Speakers: 🎤 Kaitlin DeMarco - Locust Walk 🎤 Patric Stenberg – Gesynta Pharma AB 🎤 Stasia Obremskey – Foreground Capital ► 𝗥𝗲𝗴𝗶𝘀𝘁𝗲𝗿 𝗵𝗲𝗿𝗲: https://lnkd.in/eFyg7iyk #womenshealth #startups #innovation #biotech #biopharma #venturecapital

Our Managing Partner Stasia Obremskey spoke at the SVB event: "Trailblazers & Trendsetters: Investing in Women, Innovation & Wealth" on the panel “A Deep Dive into SVB’s Women’s Health Report” to examine the funding landscape and groundbreaking innovations transforming women’s health.  Great conversation alongside: ⭐ Jessica Karr | General Partner, Coyote Ventures ⭐Gloria Lau | Co-Founder & CEO, Hello Alpha ⭐Anu Sharma | Founder & CEO, Millie Thank you SVB for a memorable day! #womenshealth #healthcare #femtech #womensupportingwomen #femaleempowerment

🚨 𝗦𝗶𝗦 𝗦𝗼𝗹𝘃𝗲 𝗣𝗶𝘁𝗰𝗵𝗶𝗻𝗴 𝗖𝗼𝗺𝗽𝗲𝘁𝗶𝘁𝗶𝗼𝗻 𝗗𝗲𝗮𝗱𝗹𝗶𝗻𝗲 𝗧𝗛𝗜𝗦 𝗙𝗿𝗶𝗱𝗮𝘆 (𝗠𝗮𝗿𝗰𝗵 𝟮𝟴)! 🚨 This is your last chance to apply for the 𝗦𝗶𝗦 𝗦𝗼𝗹𝘃𝗲 𝗣𝗶𝘁𝗰𝗵𝗶𝗻𝗴 𝗖𝗼𝗺𝗽𝗲𝘁𝗶𝘁𝗶𝗼𝗻 and showcase your groundbreaking solutions to top investors, multinationals, and women’s health leaders! 🌟 𝗪𝗵𝗮𝘁’𝘀 𝗮𝘁 𝘀𝘁𝗮𝗸𝗲? 🌟 💰 $𝟰𝟬𝗞 𝗘𝘅𝗶𝘁 𝗦𝘁𝗿𝗮𝘁𝗲𝗴𝘆 𝗣𝗿𝗼𝗴𝗿𝗮𝗺 (The Grafter) 💰 $𝟯𝟬𝗞 𝗕𝗿𝗮𝗻𝗱 𝗘𝘃𝗼𝗹𝘂𝘁𝗶𝗼𝗻 𝗣𝗿𝗼𝗴𝗿𝗮𝗺 (Alfa Charlie) 💰 $𝟮𝟱𝗞 𝗣𝗿𝗼𝗱𝘂𝗰𝘁 𝗜𝗻𝗻𝗼𝘃𝗮𝘁𝗶𝗼𝗻 𝗣𝗿𝗼𝗴𝗿𝗮𝗺 (Femovate by Guidea) Take the stage to impress our investors: Annie Theriault - Cross-Border Impact Ventures Nika Duan - Inflect Jessica Kamada - Swizzle Ventures  Elizabeth Bailey - Foreground Capital Dominnique Karetsos - Amboy Street Ventures 🔗 𝗔𝗽𝗽𝗹𝘆 𝗡𝗼𝘄 to gain exposure, credibility, and the chance to win incredible prizes while connecting with decision-makers actively seeking their next investment in women’s health! 👉 https://lnkd.in/eK6wTqp5 ⏳ 𝗗𝗲𝗮𝗱𝗹𝗶𝗻𝗲: Friday, March 28 📅 𝗣𝗶𝘁𝗰𝗵 𝗗𝗮𝘁𝗲: May 15 #Innovation #WomensHealth #PitchDay

Tomorrow is our Women's Health Conference in NYC and in anticipation of this spectacular event we are realeasing our latest NEBGH Voices Podcast Episode, "Why is Women’s Health a Strategic Imperative for Employers?" Women’s health is not just a healthcare issue—it’s a business priority. In this episode of NEBGH Voices, we sit down with Elizabeth Bailey, Co-Founder & Managing Partner at Foreground Capital, to explore why investing in women’s health drives better outcomes for employees and employers alike. From market growth to workplace impact, tune in for expert insights on the future of women’s healthcare benefits and innovation. Check it out, and don’t forget to subscribe and share! https://lnkd.in/ei24yAK6

Novocuff, Inc. was highlighted among 11 medical device startups that could change the future of healthcare! "Novocuff is the creator of a medical device that supports and closes the cervix during pregnancy to combat premature rupturing of membranes in mothers during the prebirth stage, so that pregnancy can be extended and premature births prevented. The company’s direction was influenced by real-life events: co-founder Donald Lee’s twins were delivered at only 24 weeks. It cites World Health Organization statistics stating that some one million deaths were caused by preterm birth complications in 2020." CC: Amelia Degenkolb

Don't miss the HITLAB virtual panel next week featuring our partner Alice Zheng! Sign up here ➡️ https://lnkd.in/deMWfyX4 Ft: Subrata Bose PhD, MBA, MSc, BPharma (Bayer), Walter "Buzz" Stewart (Medcurio), Lernik Essayei (Accenture)

Throwback Thursday! Earlier this month, our Managing Partner,Elizabeth Bailey, spent time in NYC workshopping potential solutions to reimbursement in women's health, along with several of Foreground’s portfolio companies, Amelia Degenkolb (Novocuff, Inc.), Laine Bruzek (Evvy), Julia A. Cole (Seven Starling) and other entrepreneurs, clinicians, investors and policymakers! 🎉 Thank you Jodi Neuhauser, Candace McDonald and their newly formed Women's Health Collective, for organizing a great event!

A big congratulations to Akash Bakshi, Nadja Mannowetz, and the entire YourChoice Therapeutics team on publishing their early human trial results on their hormone-free birth control pill for men in Nature's Communications Medicine: https://lnkd.in/d9pPBgHf! Check out the full study here: